1. New Generic Drug

 2.  Drug For Research Use Only

 3. Biopharmaceuticals

 4. Drug With Slow Release Or Target Delivery Systems

 5. Medical Device

 6. Personal Care Products

 7. Products with EU/US Registration

1. Infectious Diseases
2. Cardiovascular
3. Diabetes and Metabolic
4. Neurological
5. Autoimmune
6. Cancer
7. Liver Diseases

  Pharmaceutical Materials: Pharmaceutical Intermediate (PI) and Active Pharmaceutical Ingredients (API)

1. Collaboration with Chinese pharmaceutical companies to provide PI and API to other pharmaceutical companies in the world.
2. R & D department has the new designs of molecular drugs and precursor of small molecule drugs.
3. The 30+ of PIs and APIs for cardiovascular and cancer drugs are continuously developing, all the products meet the CGMP requirements.